|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Brucella Antibody
Test CodeBRUC
Preferred Specimen
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Refrigerated: 14 days
Methodology
Direct Agglutination (DA)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
At U of I Hygienic lab discression
Report Available
5-10 days
Reference Range
<1:80 titer
Clinical Significance
Brucella is transmitted to humans from animals. Detection of agglutinating antibodies at titers of 1:80 or greater indicates Brucella infection. Recent Brucella infection is best demonstrated by a 4-fold increase in agglutinating antibody titer when testing acute and convalescent sera in parallel.